These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 12778855
1. [Effect of strontium on bone metabolism in hemodialysis patients]. Gerstenfeld S, Hinojosa L, Serrano Arias M, Menéndez Rodríguez P, Fernández Martín JL, Marchante JM, García Alonso JI, Sanz-Medel A, Cannata Andía JB. Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855 [Abstract] [Full Text] [Related]
7. Different patterns of renal osteodystrophy in Iberoamerica. Jorgetti V, López BD, Caorsi H, Ferreira A, Palma A, Menendez P, Douthat W, Olaizola I, Ribeiro S, Jarava C, Moreira E, Cannata J. Am J Med Sci; 2000 Aug; 320(2):76-80. PubMed ID: 10981479 [Abstract] [Full Text] [Related]
9. Bone aluminum and histomorphometric features of renal osteodystrophy. Hodsman AB, Sherrard DJ, Alfrey AC, Ott S, Brickman AS, Miller NL, Maloney NA, Coburn JW. J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841 [Abstract] [Full Text] [Related]
10. [A study using nondecalcified bone biopsy of the incidence and presentation forms of renal osteodystrophy]. Lorenzo Sellares V, Torres Ramírez A, Hernández Marrero D, Rodríguez Pérez J, González Posada J, Losada Cabrera M, Maceira Cruz B, Hernández Nieto L. Med Clin (Barc); 1991 Apr 20; 96(15):561-5. PubMed ID: 2051811 [Abstract] [Full Text] [Related]
11. [Biochemical and histological spectrum of renal osteodystrophy in Argentina]. Douthat WG, Garay G, de Arteaga J, Fernández Martín JL, Cannata Andía JB, Massari PU. Nefrologia; 2003 Apr 20; 23 Suppl 2():47-51. PubMed ID: 12778854 [Abstract] [Full Text] [Related]
15. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Moore C, Yee J, Malluche H, Rao DS, Monier-Faugere MC, Adams E, Daramola-Ogunwuyi O, Fehmi H, Bhat S, Osman-Malik Y. Clin J Am Soc Nephrol; 2009 Sep 20; 4(9):1484-1493. PubMed ID: 19713297 [Abstract] [Full Text] [Related]
16. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Spasovski GB, Bervoets AR, Behets GJ, Ivanovski N, Sikole A, Dams G, Couttenye MM, De Broe ME, D'Haese PC. Nephrol Dial Transplant; 2003 Jun 20; 18(6):1159-66. PubMed ID: 12748350 [Abstract] [Full Text] [Related]
17. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3]. Giachino G, Giacchino F, Jeantet A, Del Piano A, Garetto A, Pellerey M, Piccoli G. Minerva Med; 1985 Mar 10; 76(9-10):407-14. PubMed ID: 2984605 [No Abstract] [Full Text] [Related]
18. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats. Oste L, Bervoets AR, Behets GJ, Dams G, Marijnissen RL, Geryl H, Lamberts LV, Verberckmoes SC, Van Hoof VO, De Broe ME, D'Haese PC. Kidney Int; 2005 Mar 10; 67(3):920-30. PubMed ID: 15698431 [Abstract] [Full Text] [Related]
20. Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate. Ballanti P, Coen G, Mazzaferro S, Taggi F, Giustini M, Calabria S, Ferrannini M, Bonucci E. Histopathology; 2001 Jun 10; 38(6):571-83. PubMed ID: 11422502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]